IGC Pharma (IGC) FCF Margin (2010 - 2025)
IGC Pharma (IGC) posted quarterly FCF Margin of 1109.42% for Q3 2025, down 86064.0% year-over-year from N/an in Q3 2024, and down 157.17% quarter-over-quarter from 431.4% in Q2 2025.
IGC Pharma (IGC) FCF Margin (2010 - 2025) Analysis & Trends
IGC Pharma (IGC) has reported FCF Margin for 16 consecutive years, with 1109.42% the latest figure, recorded in Q3 2025.
- In Q3 2025, FCF Margin fell 86064.0% year-over-year to 1109.42%; the TTM figure through Sep 2025 stood at 508.68% (down 8510.0% YoY), while the FY2026 annual figure was 386.12%, down 5.0% from the prior year.
- FCF Margin slipped to 1109.42% in Q3 2025 per IGC's latest filing, from 431.4% in the prior quarter.
- Across five years, FCF Margin topped out at 183.39% in Q1 2024 and bottomed at 4907.41% in Q1 2021.
- Historically, FCF Margin has averaged 1177.6% across 5 years, with a median of 671.69% in 2022.
- On a YoY basis, FCF Margin climbed as much as 442708 bps in 2021 and fell as far as 201433 bps in 2021.
- IGC Pharma's FCF Margin stood at 1685.92% in 2021, then soared by 60 bps to 671.69% in 2022, then fell by 21 bps to 811.27% in 2023, then surged by 36 bps to 522.96% in 2024, then tumbled by 112 bps to 1109.42% in 2025.
- Business Quant data shows IGC's FCF Margin at 1109.42% in Q3 2025, 431.4% in Q2 2025, and 226.67% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 30.39% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 13.35% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -388.28% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 25.68% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 22.62% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -22.35% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 70.82% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | 41.07% |
| 10 | IGC Pharma | 27.20 Mn | 26.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -1,109.42% |
| Jun 30, 2025 | -431.40% |
| Mar 31, 2025 | -226.67% |
| Dec 31, 2024 | -522.96% |
| Sep 30, 2024 | -248.79% |
| Jun 30, 2024 | -658.09% |
| Mar 31, 2024 | -183.39% |
| Dec 31, 2023 | -811.27% |
| Sep 30, 2023 | -568.04% |
| Jun 30, 2023 | -268.11% |
| Mar 31, 2023 | -916.87% |
| Dec 31, 2022 | -671.69% |
| Sep 30, 2022 | -634.65% |
| Jun 30, 2022 | -1,095.75% |
| Mar 31, 2022 | -925.41% |
| Dec 31, 2021 | -1,685.92% |
| Sep 30, 2021 | -3,983.93% |
| Jun 30, 2021 | -2,524.68% |
| Mar 31, 2021 | -4,907.41% |
| Dec 31, 2020 | -1,708.33% |